Abstract:Direct enantiomeric resolution of two synthesized organic phosphonate derivatives [(2-Chloro-phenylamino)-(2-hydroxy-phenyl)-methyl]-phosphonic acid diethyl ester (compound 1) and [(2-Chloro-phenyl)-(4-fluoro-phenylamino)-methyl]phosphonic acid diethyl ester (compound 2) has been achieved using hexane as the mobile phase with various alcohols as modifiers. The influence of the mobile phase composition and solute structure on the chiral separation was studied. It was found that compound 1 achieved good separation on (S,S)-Whelk-O1, cellulose tris(3,5-dimethylphenylcarbamate) (CDMPC) and cellulose trisphenylcarbamate (CTPC) chiral stationary phases, while compound 2 could be separated on (R,R)3,5-dinitrobenzoyl-1,2-diphenylethane-1,2-diamine((R,R)-DNB-DPEDA) and CDMPC chiral stationary phases. Interestingly, on cellulose derivative chiral stationary phases (CSPs), acidic additive was necessary for enantioseparation of compounds 1 and 2. The chiral recognition mechanism of (S,S)-Whelk-O1, (R,R)-DNB-DPEDA and cellulose derivative CSPs was explored. On (S,S)-Whelk-O1-CSP, hydrogen-bonding interactions play an important role in chiral recognition. On (R,R)-DNB-DPEDA-CSP, the dipole-dipole interactions and pi-pi stacking are important to chiral discrimination. On (S,S)-Whelk-O1-CSP and (R,R)-DNB-DPEDA-CSP, a correlation is concluded between elution order and absolute configuration of the analytes. On cellulose CSPs, the inclusion and fitness of solute shape in the chiral cavity significantly contributed to the enantioseparation of solutes. Furthermore, as for the enantioseparation of compound 1, the hydrogen-bonding interactions play an important role on CTPC, but play a minor role on CDMPC.

Chiral Recognition Mechanisms Of Four Beta-Blockers By Hplc With Amylose Chiral Stationary Phase

Chiral Separation of Fluoxetine Hydrochloride by HPLC with Amylose Chiral Stationary Phase

Analytical Enantioseparation of N‐alkyl Drugs by Reversed‐phase Liquid Chromatography with Carboxymethyl‐β‐cyclodextrin As Mobile Phase Additive

Enantioseparation of Five Racemic N‐alkyl Drugs by Reverse Phase HPLC Using Sulfobutylether‐β‐cyclodextrin As a Chiral Mobile Phase Additive

[Enatiomeric Separation of Beta-Blocking Agents and Analogs]

Comparison of the Performance of Chiral Stationary Phase for Separation of Fluoxetine Enantiomers

Stereoselective Separation of Β-Adrenergic Blocking Agents Containing Two Chiral Centers by Countercurrent Chromatography.

Application of CHIRALPAK AD Column to Chiral Separation of Fourteen Drugs

Enantioseparation Of Aromatic Alcohol And Aromatic Ester On Chiral Stationary Phases

Enantioseparation Of D,L-Alpha-Amine Acid On Crown Ester Chiral Stationary Phases

Enantioseparation of Three Non-Steroidal Anti-Inflammatory Agents on Chiral Stationary Phase by HPLC

Progress in the Enantioseparation of -Blockers by Chromatographic Methods

Enantioseparation of Benazepril Intermediates by High‐Performance Liquid Chromatography on Chiral CDMPC Column

Enantioseparation and Chiral Recognition Mechanism of Two Novel Organic Phosphonate Derivatives on Chiral Stationary Phases

Separation of Beta-Receptor Blockers and Analogs by Capillary Liquid Chromatography (clc) and Pressurized Capillary Electrochromatography (pcec) Using A Vancomycin Chiral Stationary Phase Column

Enantioseparation Of Etodolac And Its Intermediate On Chiral Stationary Phase By High Pherformance Liquid Chromatography

Chiral Separation Of Bisoprolol, Atenolol, Clenteral And Terbutaline By Capillary Chromatography

Chiral separation of propranolol hydrochloride by smb process integrated with crystallization

Enantioseparation of Four Aryloxyphenoxypropionic Acid Herbicides by HPLC on CDMPC and (S,s)-Whelk-o 1

Progress in the Enantioseparation of Β-Blockers by Chromatographic Methods

Chiral phenethylamine synergistic tricarboxylic acid modified ,B-cyclodextrin immobilized on porous silica for enantioseparation